Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

Clinical trial NCT04085367 · COMPLETED

Trial details

NCT number: NCT04085367
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratoses

Start date: 2019-09-30
Primary completion: 2021-03-03
Enrollment: 557

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.